Posts
October 05 2023
Syra Health Corp., a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced the closing of its upsized initial public offering in the amount of $6,700,000. EGS acted as counsel to the underwriter.
October 05 2023
Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced the pricing of its registered direct offering in the amount of $1,600,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.
October 04 2023
EGS is pleased to announce the addition of Gregg M. Kligman as Partner to our Labor & Employment Practice Group.
Click here to read the announcement.
October 02 2023
Lexaria Bioscience Corp. announced the closing of its Registered Direct offering in the amount of $1,600,000. EG&S acted as counsel to the Placement Agent.
September 30 2023
Terran Orbital Corporation announced the closing of its Public Offering in the amount of $32,500,000. EG&S acted as counsel to the Placement Agent.
September 28 2023 Event
Amanda Fugazy, a member of the Firm, was invited by the New York State Restaurant Association to speak at their NYSRA Leadership & Operations Symposium on November 6th in New York City. Ms. Fugazy will be speaking on the Top 10 Legal Mistakes Made by Foodservice Operators.
Click here to register.
September 27 2023
Terran Orbital Corporation announced the closing of its Public Offering in the amount of $32,500,000. EG&S acted as counsel to the Placement Agent.
September 25 2023
Cellectar Biosciences, Inc. announced the closing of its Private Placement Offering in the amount of $103,000,000. EG&S acted as counsel to the Placement Agent.